These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12971677)

  • 21. Drug resistance and HIV co-infection among pulmonary tuberculosis patients in Haiphong City, Vietnam.
    Khuê PM; Phuc TQ; Hung NV; Jarlier V; Robert J
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):763-8. PubMed ID: 18544201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multi-drug-resistant tuberculosis in a Department of Infectious Diseases].
    Constant CA; Ferreira PB; Valadas E; Antunes F
    Acta Med Port; 2004; 17(2):157-66. PubMed ID: 15921647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tuberculosis and its control--lessons from the past and future prospect].
    Shimao T
    Kekkaku; 2005 Jun; 80(6):481-9. PubMed ID: 16130906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HIV-tuberculosis time bomb: how can hospitals in developing countries cope?
    Walley J
    World Hosp Health Serv; 1994; 30(1):16-9. PubMed ID: 10135090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.
    Keshavjee S; Gelmanova IY; Pasechnikov AD; Mishustin SP; Andreev YG; Yedilbayev A; Furin JJ; Mukherjee JS; Rich ML; Nardell EA; Farmer PE; Kim JY; Shin SS
    Ann N Y Acad Sci; 2008; 1136():1-11. PubMed ID: 17954675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings.
    Scano F; Vitoria M; Burman W; Harries AD; Gilks CF; Havlir D
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1370-5. PubMed ID: 19017444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Special report. The new TB epidemic hits hospitals: causes, transmission, precautions.
    Hosp Secur Saf Manage; 1992 May; 13(1):5-9. PubMed ID: 10128719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tuberculosis in Poland, Europe, and world. Part II--mortality, drug resistance and HIV infection].
    Zielonka TM
    Pol Merkur Lekarski; 2006 Sep; 21(123):253-61. PubMed ID: 17163187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis and HIV infection in Brazil -- update and overview.
    Dalcolmo M
    TB HIV; 1996; (11):26. PubMed ID: 12179806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculosis in children with human immunodeficiency virus infection.
    Chintu C; Mwaba P
    Int J Tuberc Lung Dis; 2005 May; 9(5):477-84. PubMed ID: 15875917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation.
    Caminero JA
    Int J Tuberc Lung Dis; 2008 Aug; 12(8):869-77. PubMed ID: 18647445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia.
    Ruddy M; Balabanova Y; Graham C; Fedorin I; Malomanova N; Elisarova E; Kuznetznov S; Gusarova G; Zakharova S; Melentyev A; Krukova E; Golishevskaya V; Erokhin V; Dorozhkova I; Drobniewski F
    Thorax; 2005 Feb; 60(2):130-5. PubMed ID: 15681501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual epidemic is developing in Russia. Co-infection (HIV / TB).
    AIDS Wkly; 2000 Sep; ():8. PubMed ID: 12322630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
    Ormerod LP
    Br Med Bull; 2005; 73-74():17-24. PubMed ID: 15956357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB.
    Martinez L; Blanc L; Nunn P; Raviglione M
    Travel Med Infect Dis; 2008 Jul; 6(4):177-81. PubMed ID: 18571104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.